Jasper Therapeutics, Inc.·4

Oct 13, 8:00 PM ET

Nolet Chris 4

4 · Jasper Therapeutics, Inc. · Filed Oct 13, 2022

Insider Transaction Report

Form 4
Period: 2022-10-12
Nolet Chris
Director
Transactions
  • Award

    Voting Common Stock

    2022-10-12+32,50032,500 total
Footnotes (1)
  • [F1]The reported securities are represented by restricted stock units, 1/2 of which shall vest on each of April 12, 2023 and October 12, 2023, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file
  • 4
    ownership.xmlPrimary